2024-518898-34-00RecruitingPhase 2/3
A clinical study is aimed at comparing the effectiveness of two types of cell therapy in treating anal fistulas associated with Crohn's disease.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 11 Mar 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2/3
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- First submitted
- 22 Jan 2025
- Start date
- 21 Apr 2026
- Lead sponsor
- Uniwersytet Jagiellonski Collegium Medicum
- Diseases
- Crohn's disease
- EU CT number
- 2024-518898-34-00
- EudraCT number
- 2022-003197-23
What you commit to
- Study type: Interventional · Phase 2/3
- Planned participants: 48
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with an anal fistula linked to Crohn's disease. It compares two types of cell therapy.
- Age
- 18 years or older
- Sex
- Women and men can both join.
- Disease stage
- An anal, recto-cutaneous or recto-vaginal fistula related to Crohn's disease.
Main reasons for not taking part
- Healthy volunteers cannot join.
Read by machine on 9 Nov 2026.
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Szpital Specjalistyczny Im. Ludwika Rydygiera W Krakowie Sp. z o.o. | Cracow | Poland | Recruiting |
| 5 Wojskowy Szpital Kliniczny Z Poliklinika Samodzielny Publiczny Zaklad Opieki Zdrowotnej W Krakowie | Cracow | Poland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.